| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2172730 | Cytotherapy | 2011 | 10 Pages |
Abstract
These data suggest that hematopoietic cell preparations containing monocytes bear the risk of foam cell formation after pro-angiogenic induction. Instead, EPC and MSC may drive vascular regeneration without atherogenesis aggravation. A thorough understanding of cell biology is necessary to develop new strategies combining pro-angiogenic and anti-atherogenic effects during cell therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Eva Rohde, Katharina Schallmoser, Andreas Reinisch, Nicole A. Hofmann, Thomas Pfeifer, Eleonore Fröhlich, Gerald Rechberger, Gerhard Lanzer, Dagmar Kratky, Dirk Strunk,